Argenx
ARGX
#546
Rank
ยฃ29.47 B
Marketcap
ยฃ492.93
Share price
-2.22%
Change (1 day)
37.14%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: ยฃ29.47 Billion

As of December 2024 Argenx has a market cap of ยฃ29.47 Billion. This makes Argenx the world's 546th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2024

201620192022ยฃ5Bยฃ10Bยฃ15Bยฃ20Bยฃ25Bยฃ30Bcompaniesmarketcap.com

End of year Market Cap

Year Marketcap Change
2024ยฃ29.47 B66.4%
2023ยฃ17.71 B2.25%
2022ยฃ17.32 B27.16%
2021ยฃ13.62 B32.44%
2020ยฃ10.28 B96.11%
2019ยฃ5.24 B89.91%
2018ยฃ2.76 B86.2%
2017ยฃ1.48 B
2014ยฃ93.47 M

End of Day market cap according to different sources

On Dec 17th, 2024 the market cap of Argenx was reported to be:

ยฃ30.14 Billion
by Yahoo Finance info icon info icon
ยฃ30.14 Billion
by CompaniesMarketCap info icon info icon
ยฃ29.84 Billion
by Nasdaq info icon info icon